Abstract Plasminogen activator (PA) and PA inhibitor (PAI) antigen, activity, and mRNA were analyzed in the three layers of rat aorta, and the effect of endotoxin on PA and PAI was studied. All PA activity in aorta was identified as tissue-type PA (TPA) activity; no urokinase-type PA was detected. In the tunica adventitia TPA activity, TPA antigen, and TPA mRNA were detected, whereas in the tunica media TPA antigen and TPA mRNA, but no TPA activity, were found. PAI activity was detected in the tunica media, explaining the absence of TPA activity in this layer. Removal of the endothelial cells had no effect on TPA antigen and PAI activity in intima-media preparations. Also, similar amounts of PAI-1 mRNA were found in intima-media preparations, irrespective of the presence or absence of the intima. Immunohistochemical staining showed that TPA immunoreactivity was present in all three layers of the P lasminogen is azymogen that can be converted to the active serine protease plasmin by plasminogen activators. Plasmin is involved in a broad spectrum of extracellular proteolytic processes, including fibrinolysis, thrombolysis, cell migration, and tissue remodeling.
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Abstract Plasminogen activator (PA) and PA inhibitor (PAI) antigen, activity, and mRNA were analyzed in the three layers of rat aorta, and the effect of endotoxin on PA and PAI was studied. All PA activity in aorta was identified as tissue-type PA (TPA) activity; no urokinase-type PA was detected. In the tunica adventitia TPA activity, TPA antigen, and TPA mRNA were detected, whereas in the tunica media TPA antigen and TPA mRNA, but no TPA activity, were found. PAI activity was detected in the tunica media, explaining the absence of TPA activity in this layer. Removal of the endothelial cells had no effect on TPA antigen and PAI activity in intima-media preparations. Also, similar amounts of PAI-1 mRNA were found in intima-media preparations, irrespective of the presence or absence of the intima. Immunohistochemical staining showed that TPA immunoreactivity was present in all three layers of the P lasminogen is azymogen that can be converted to the active serine protease plasmin by plasminogen activators. Plasmin is involved in a broad spectrum of extracellular proteolytic processes, including fibrinolysis, thrombolysis, cell migration, and tissue remodeling. 1 Two types of endogenous plasminogen activators (PA) have been described: tissue-type PA (TPA) and urokinase-type PA (UPA). The activity of both activators is regulated by specific inhibitors: plasminogen activator inhibitor type-1 (PAI-1), PAI type-2 (PAI-2), and protease nexin-1. 2 These inhibitors exert a regulatory role in extracellular proteolytic processes, including fibrinolysis/thrombolysis.
Thrombi may form either on the endothelial cells (ECs) that form the innermost lining of a vessel 3 or on subendothelial cells or structures, for instance, on ulcerated or fissured plaques where endothelial cells are no longer present. 4 Despite the importance of PAs and PAIs for the subsequent lysis of thrombi, the distribution of PAs and PAIs in normal and diseased vessel walls is still largely unexplored. 59 In a previous study we showed that coincubation of intact rat aorta with UP A or TPA results in a loss of PA activity and in the formation of high-molecular-weight PA complexes. 10 Extracts of whole rat aorta contain both TPA antigen and TPA activity 11 and show, on fibrin autography, two areas of TPA activity, one due to free TPA and the second due to a TPA/PAI complex. 11 Together, these observations suggest that in normal rat aorta both TPA and PAI are present, with TPA present in excess over PAI. Treatment of animals with endotoxin reduces TPA activity in the aorta, 12 possibly due to a shift in the balance between activator(s) and inhibitor(s).
In the present study we analyzed the distribution of PAs and PAIs in the three layers of rat aorta: intima, media, and adventitia. Each of these three layers contains a homogeneous cell population: ECs in the intima, smooth muscle cells (SMCs) in the media, and fibroblasts with occasional capillary ECs in the adventitia. 1315 As the three layers of rat aorta can easily be separated by physical manipulation, 16 this artery is well suited for analyzing, qualitatively and quantitatively, the distribution of PAs and PAIs in an arterial vascular tissue. For this analysis, physical separation is preferred over enzymatic separation, since proteolytic digestion of tissue may result in the induction of at least some species of mRNA, 17 making it hazardous to extrapolate data so obtained to the in vivo situation. The same reservations apply to data obtained in cell cultures. 18 In the present study we describe the in vivo distribution of PAs and PAIs in the three layers of rat aorta and their modulation by endotoxin. On the basis of these data, we suggest that major differences may exist regarding the distribution of PAs and PAIs between vessel walls from various species or from various sites in the body.
(Nembutal, Sanofi) anesthesia (60 mg/kg IP). Endotoxin (Escherichia coli serotype 0128 :B12, Sigma) was intravenously injected at a dose of 50 /ig/kg. Control rats were injected with sterile saline (1 mL/kg), which was free of endotoxin as determined by the Coatest Endotoxin (Chromogenics). Three hours after the injection, just before maximal plasma PAI activity, 12 the animals were bled by carotid cannulation. The aortas were rapidly dissected from the aortic arch to the bifurcation and were cleaned of connective tissue and fat. After a brief rinse with saline, the vessel was opened longitudinally, and the media was completely dissected from the adventitia. 16 In half of the aortas studied (both control and endotoxin treated), the endothelium was removed by scraping with the blunt part of a scalpel (the presence of the endothelium on the untreated vessel and the successful removal of the endothelium from the scraped vessel were confirmed by scanning electron microscopy). Tissue samples were immediately frozen in liquid nitrogen and stored at -70°C. Samples for mRNA evaluation were processed immediately.
Animal experiments had been approved by the Animal Experiments Committee of the Netherlands Organization for Applied Scientific Research TNOF and were in accordance with the guidelines on animal experimentation presented to the International Committee of Thrombosis and Haemostasis.
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Tissue Extraction and Analysis
Tissue was triturated in liquid nitrogen and homogenized (40 mg wet wt/mL) in the extraction buffer for 1 minute at 4°C by means of a Polytron-7 blender. After centrifugation of the homogenate for 10 minutes at 3000g (4°C), the supernatant was filtered (Gelman Acrodisc; pore size, 1.2 /xm) and stored at -70°C.
n For the extraction buffer, we used an acid acetate buffer (75 mmol/L acetic acid, 225 mmol/L NaCl, 75 mmol/L KC1, 10 mmol/L EDTA, 100 mmol/L arginine, and 0.25% Triton X-100, pH 4.2). 20 The concentration of tissue extract will be expressed as milligrams of initial wet weight per milliliter.
Fibrin Autography
Tissue extracts were subjected to sodium dodecyl sulfate (SDS)-polyacrylamide gel electrophoresis, 21 with a 4% stacking gel and a 9% separating gel. After electrophoresis, the gels were washed in 2.5% Triton X-100 and incubated on a plasminogen-rich fibrin-agarose underlay.
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TPA Activity and Antigen Assays
PA activity in tissue extracts was evaluated spectrophotometrically 23 in the presence and absence of anti-rat TPA I g G n.i2 xhis antibody quenches the activity of TPA but not of UP A, as shown spectrophotometrically (Fig 1) and by fibrin autography (compare Fig 4c in Reference 11) . The difference between the activities with and without anti-rat TPA IgG was taken as TPA activity. TPA activity will be expressed in units, with 1 U defined as that amount of rat TPA that gives the same rate of change in absorption in our assay as 1 ng of recombinant human TPA (rTPA) (Activase, Genentech). TPA antigen concentrations were determined by means of an enzymelinked immunoabsorbent assay (ELISA) (Imulyse; Biopool). Rat TPA purified from the yolk sac tumor cell line L 2 25 was used as standard.
PAI Activity Assay
A spectrophotometric assay was used to evaluate PAI activity, 26 using (r)TPA for titration. Results will be expressed in units, with 1 U of rat PAI activity defined as that amount of PAI activity that inhibits 1 ng of human rTPA.
RNA Isolation and mRNA Analysis
Tissues were immediately homogenized in 4 mol/L guanidine thiocyanate, 25 mmol/L sodium citrate (pH 7.5), 0.5% sarkosyl, and 0.1 mol/L 2-mercaptoethanol. RNA was isolated 24 (10 jtL of a solution of 2.5 ng/mL) was fully quenched by rabbit anti-rat TPA IgG (•), whereas the PA activity of rat urine (10 fit, 1:10 diluted) was not affected by anti-rat TPA IgG (•). The PA activity in 10 ^.L extract from rat kidney (prepared as described for rat aorta; see "Methods") was for 10% inhibited by anti-rat TPA IgG (o); the remaining 90% of the PA activity of the extract was quenched by a rabbit anti-murine urokinase-type PA (UPA) IgG that cross-reacts with rat UPA (o). This anti-UPA IgG also fully inhibited the activity of the sample of rat urine (not shown). All activities were determined spectrophotometrically, as described in "Methods."
from the homogenate according to Chomczynski and Sacchi. 27 Total RNA was quantified by absorbance at 260 nm. RNA samples were electrophoresed on a 1.2% agarose gel containing 7.5% formaldehyde. The RNAs were transferred to a nylon membrane (Hybond N, Amersham) by means of a Vacugene system (Pharmacia). The membranes were hybridized with labeled cDNA fragments at 60°C in a solution containing 7% SDS, 0.5 mol/L Na 2 HPO4/NaH 2 PO 4 (pH 7.2), and 10 mmol/L EDTA. The blots were routinely washed with 2x SSC/1% SDS for 1 hour at 60°C (lx SSC=0.15 mol/L NaCl, 0.015 mol/L sodium citrate). Autoradiograms were prepared with Kodak XAR-5 film and intensifying screens at -70°C.
The following cDNA fragments were used as probes in the hybridization experiments 12 : a 1.9-kb Bgl II fragment of the human TPA cDNA, 28 a 1.0-kb £coRI Pst I fragment of the human UPA cDNA 29 kindly provided by Dr W.-D. Schleuning, a 0.9-kb Pvu II fragment of the rat PAI-1 cDNA 30 kindly provided by Drs T.D. Gelehrter and R. Zeheb, and a 1.2-kb Pst I fragment of the rat glyceraldehyde-3-phosphate dehydrogenase cDNA 31 kindly provided by Dr R. Offringa. The cDNA fragments were labeled with [ 
Immunohistochemistry
For immunohistochemical studies the avidin-biotin-peroxidase complex (ABC) technique of Hsu et al 32 was used. Total aortas were dissected and stored in liquid nitrogen. Frozen sections were air dried, fixed for 5 minutes in acetone, and washed in phosphate-buffered saline (PBS). After preincubation for 10 minutes in normal serum, sections were incubated for 2 hours with primary antibody, either rabbit anti-rat PAI-1 IgG 33 (American Diagnostica, dilution, 1:200) or rabbit antirat TPA IgG (dilution, 1:2000). The sections were then washed in PBS and incubated sequentially with biotinylated secondary antibody and preformed ABC (Vector Laboratories). Bound peroxidase was visualized with diaminobenzidine, and sections were counterstained with hemalum. For control sections, nonimmune rabbit IgG was used as the primary antibody, followed by biotinylated secondary antibody and preformed ABC. 
Results
Injection of rats with endotoxin (50 jug/kg) results in a strong decrease of TPA activity in the aorta (by 71% at 3 hours after injection) and an approximately 40-fold increase in plasma PAI activity, as described.
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- 34 In this study changes in TPA and PAI in the aorta were analyzed in further detail, using the same endotoxin injection scheme.
PA Activity
Because of the small amount of vascular tissue, for each individual extract the aortas (or aortic layers) from two rats were pooled before extraction. PA activity was first analyzed qualitatively by fibrin autography (Fig 2) . A lysis area caused by uncomplexed, free TPA was observed in extracts of the media, with or without endothelium, and of the adventitia. No lysis area was ever found in the rat UPA position, using media extracts or adventitia extracts (Fig 2) or extracts from whole aorta. 11 Tissue extracts of aortic layers from endotoxintreated rats showed a smaller band at the TPA position than extracts from control rats. All extracts showed a band at the TPA/PAI complex position.
Quantitative evaluation of PA activity by spectrophotometry (Table) showed a detectable value only in the adventitia. In the media, with and without endothelium, no PA activity was detected. The adventitial PA activity was completely blocked when samples were evaluated in the presence of anti-rat TPA IgG. TPA activity in the adventitia was decreased by 75% (P<.01) in the endotoxin-treated rats compared with control rats (Table) .
TPA Antigen
TPA antigen was detected in extracts from both media and adventitia (Table) . Because no significant differences in TPA antigen concentration between media with and media without endothelium were detected, the values for media plus endothelium and media minus endothelium have been combined in the Table. No differences in TPA antigen levels were observed between control rats and endotoxin-treated rats.
PAI Activity
Spectrophotometric analysis of PAI activity showed that such activity could be detected only in media extracts, not in adventitia extracts (Table) . Again, no significant differences were observed between media plus intima and media minus intima. Mean PAI activity values (n=3) were 190 U/g wet tissue wt for media plus intima versus 195 U/g for media minus intima in control rats; values in endotoxin-treated rats were 263 U/g versus 304 U/g. Endotoxin treatment thus increased PAI activity in the media by 48% (Table; P<.0\). When PAI activity in the media was evaluated in both the presence and absence of anti-rat PAI-1 IgG, 33 PAI activity was decreased by only 29% in the control group and only 54% in the endotoxin-treated group. The residual (non-PAI-1-related) inhibitory activity averaged 136 U/g for the control group and 131 U/g for the endotoxin-treated group (compare the Table) . This demonstrated that the endotoxin-induced increase in medial PAI activity was due to an increase in PAI-1, while the non-PAI-1-related inhibitory activity remained unchanged. The increase in PAI-1 activity was approximately threefold (from an average of 56 U/g in control media to 153 U/g in endotoxin-treated media).
mRNA Analysis: PAI-1
To determine whether the effect of endotoxin treatment on PAI activity was due to increased local synthesis of PAI-1, we determined the mRNA levels for PAI-1 in the total aorta of control and of endotoxin-treated rats. Endotoxin increased the mRNA levels for PAI-1 markedly (Fig 3) . To determine which layer of the aortic wall was responsible for PAI-1 production, mRNA was isolated from adventitia, media with endothelium, and media without endothelium. In control rats PAI-1 mRNA was detected mainly in the media, although a weak signal was also visible in the adventitia. After endotoxin treatment a strong increase of PAI-1 mRNA in the media was observed, and PAI-1 mRNA now also became clearly detectable in the adventitia (Fig 3) . Again, no difference could be detected between media plus endothelium and media minus endothelium (Fig 4) . Endotoxin (50 Aig/kg) was injected 3 hours before RNA extraction; 10 /xg total RNA was used in every lane. The filters were subsequently hybridized with cDNA fragments of human tissuetype plasminogen activator (t-PA), rat plasminogen activator inhibitor type-1 (PAI-1), and rat glyceraldehyde-3-phosphate dehydrogenase (GAPDH).
TPA mRNA levels in the different aortic layers showed that in the media, the adventitia, and the whole aorta comparable amounts of TPA mRNA were present ( Fig  3) ; endotoxin treatment increased TPA mRNA in the adventitia. UPA mRNA was detectable neither in the total aorta nor in any single layer, although the human cDNA probe we used does react with rat UPA, as we have shown previously. 12 No UPA mRNA was found after endotoxin treatment.
Immunohistochemistry
The distribution of TPA and PAI was also studied immunohistochemically on frozen aorta sections. Cells in all three aortic layers exhibited intracellular immunoreactivity for TPA. Both ECs and SMCs were stained, the ECs most intensely (Fig 5a) , whereas adventitial fibroblasts stained moderately. No staining was observed in the extracellular matrix. In normal tissue, PAI-1 immunoreactivity (Fig 5b) was found only in the Northern blots of RNA extracted from the media plus endothelium and the media minus endothelium of aortas from control (C) and endotoxin-treated (E) rats. Endotoxin (50 ^g/kg) was injected 3 hours before RNA extraction; 10 ^g total RNA was used in every lane. The filter was subsequently hybridized with cDNA fragments of rat plasminogen activator inhibitor type-1 (PAI-1) and rat glyceraldehyde-3-phosphate dehydrogenase (GAPDH). cytoplasm of SMCs, both in medial SMCs and in SMCs surrounding small arterioles in the adventitia. In the tunica media the intensity of immunostaining for PAI-1 was strongest in the cells just below the intima and near the adventitia (Fig 5b) . Endothelial cells showed no staining for PAI-1, in either normal (Fig 5b) or endotoxin-treated (Fig 5d) aorta. Endotoxin treatment did not influence the staining for TPA (not shown) and showed slightly increased staining for PAI-1 in the SMCs (Fig 5d) . Sections stained with nonimmune rabbit IgG remained unstained (Fig 5c) .
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Discussion
In the present study we took advantage of the fact that the rat aorta can mechanically be separated 16 into its three layers, containing single, well-defined cell types. This situation obviated the use of proteolytic enzymes or cell culture to isolate cells, treatments that may induce rapid changes in cellular mRNA composition.
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Medial Smooth Muscle Cells
In the media layer, which contains SMCs exclusively, 1315 we found mRNA for TPA and PAI-1, TPA antigen by immunohistochemistry and by ELISA, PAI-1 antigen by immunohistochemistry (an ELISA assay for rat PAI-1 antigen is not available), and PAI activity by spectrophotometry. We did not detect TPA activity, UPA activity, or UPA mRNA. By fibrin autography we observed two bands of activity: one at the M r of rat TPA 11 and one at the position of TPA/PAI complexes. In both bands, the activity was inhibited by anti-TPA IgG. 11 The discrepancy between the negative spectrophotometric PA activity data and the positive fibrin autography data is likely due to the fact that extracts from the media layer contain TPA/PAI complexes that have no direct enzymatic activity but that will become active and will also partly dissociate upon electrophoresis in a Laemmli system, giving rise to two TPA activity bands. 35 We conclude from our data that rat aorta medial SMCs synthesize in vivo both TPA and PAI-1, with PAI-1 present in excess over TPA. Medial SMCs contain no detectable UPA. The presence of PAI-1 synthesis in normal vascular SMCs agrees with immunohistochemical observations on the presence of PAI-1 in SMCs in human veins and umbilical artery, 36 in healthy human aorta and carotid artery, 8 and in healthy murine renal arteries. 37 It also agrees with reports on the presence of PAI-1 mRNA in arterial SMCs. 7837 However, PAI-1 mRNA has also been reported to be absent in healthy vascular SMCs, 3840 and Clowes et al 5 did not find PAI activity in extracts of (ballooned) rat carotid artery. Of note is that, in normal rat aorta, only one third of total PAI activity in the tunica media was due to PAI-1. In culture, human vascular SMCs have been shown to produce three types of inhibitory activity: PAI-1, PAI-2, and protease nexin-1, 41 and protease nexin-1 has been demonstrated immunohistochemically in vascular SMCs in human brain. 42 Which inhibitor(s) accounts for the non-PAI-1-related inhibitory activity in rat aorta SMCs in vivo could not be determined. As the non-PAI-1-related activity did not change after endotoxin injection, only PAI-1 is induced by endotoxin. The increase in PAI-1 activity was approximately threefold, in fair agreement with the mRNA data of (A discrepancy between the presence of UPA activity but the absence of UPA mRNA had also been noted previously in mouse lung. 44 ) TPA activity was not found by Clowes et al 5 in normal SMCs but only in damaged SMCs, after endothelial denudation induced by ballooning; TPA was present in endothelial cells. This distribution of TPA was confirmed by Jackson et al, 9 who additionally used an immunohistochemical technique. In agreement with our data in rat aorta, Jackson et al 9 did not find UPA activity in (uninjured) carotid artery, in contrast to the data of Clowes et al. 5 
Endothelial Cells
Because of their small mass, aortic ECs could not be separately analyzed biochemically. The presence of TPA in ECs, as demonstrated here by immunohistochemistry, confirms many previous studies, both immunohistochemical (eg, References 9 and 45 through 47) and functional, using Todd's fibrin slide technique (eg, References 47 and 48). The absence of UPA activity and UPA mRNA in extracts from total aorta and from intima-media preparations confirms the observation that no UPA is present in ECs under physiological conditions, 45 -4951 although it may be induced by a physiological process such as angiogenesis. 51 In addition, in our rats UPA was not induced by endotoxin. Because of the large amounts of PAI-1 present in the medial layer, our biochemical data did not permit us to draw conclusions regarding the presence of PAI-1 in ECs. Using immunohistochemistry, we could not demonstrate the presence of PAI-1 in normal ECs or in endotoxin-treated ECs. Published data regarding the presence of PAI-1 in ECs in vivo are conflicting. By in situ hybridization, PAI-1 mRNA was found in reportedly healthy endothelia by some authors 78 but not by others. 39 -405152 However, PAI-1 mRNA was found in ECs disturbed by atherosclerosis, 7 endotoxin, 37 surgery, 38 tumor growth, 49 or thrombosis. 52 Immunohistochemically, PAI-1 was found in ECs in human veins and the umbilical artery 36 and in the human artery. 7 Keeton et al 37 reported that, after endotoxin challenge, PAI-1 mRNA was greatly increased in (murine) renal ECs, as mentioned, but decreased in vascular renal SMCs. Our data in the rat do not agree with this observation.
Adventitia
The presence, even after endotoxin, of TPA activity in the adventitia extracts agrees with histochemical observations on the presence of strong PA activity in the adventitia from most vessels, 53 always in relation to capillaries in the adventitia. TPA mRNA could be detected in the adventitial extracts. The discrepancy between the increase in TPA mRNA (Fig 3) and the unchanged level of TPA antigen (Table) in the adventitia after endotoxin remains unexplained. The endotoxin-induced decrease in adventitial TPA activity (Table) is likely due to the increase in PAI-1 (eg, Fig 3) .
Conclusion
Our data show that rat medial SMCs synthesize large amounts of PAI-1 under physiological conditions and even more after endotoxin challenge. In contrast, no evidence for PAI-1 synthesis by ECs was found. When the estimated weights of SMCs and ECs (which in a 70-kg person amount to 2 kg for SMCs and 270 g for ECs 54 ) are taken into account, PAI-1 derived from SMCs, provided that it is released into blood or lymph, may even be of major importance for maintaining steady-state PAI-1 levels in the circulation. Of note in this respect is that, of all rat tissues tested, only the aorta (aortic media) contained excess PAI-1 activity over TPA activity (compare Reference 11). The production of plasminogen activators and their inhibitors by vascular SMCs and adventitial tissue might indicate that, in addition to the well-documented role of the PA system during proteolysis in the circulation, a major role in local vessel wall proteolytic processes, such as cell migration, should be considered (eg, see References 1, 5, and 9). The excess PAI activity found in the tunica media may also help to explain the resistance of vessel walls to tumor cell invasion. 
